Jlenia Brunetti Selected Research

Jlenia Brunetti Research Topics

Disease

16	Neoplasms (Cancer) 12/2020 - 09/2007
8	Infections 01/2020 - 07/2012
3	Breast Neoplasms (Breast Cancer) 11/2020 - 12/2015
3	Sepsis (Septicemia) 01/2020 - 07/2012
2	Ciliopathies 07/2021 - 01/2021
2	Inflammation (Inflammations) 01/2018 - 12/2016
2	Bacterial Infections (Bacterial Infection) 01/2017 - 12/2016
1	COVID-19 01/2021
1	Bardet-Biedl syndrome 1 01/2021
1	Triple Negative Breast Neoplasms 11/2020
1	Pseudomonas Infections 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 04/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015
1	Rheumatoid Arthritis 06/2014
1	Melanoma (Melanoma, Malignant) 06/2014
1	Colonic Neoplasms (Colon Cancer) 04/2011
1	Rhabdomyosarcoma 04/2011
1	Septic Shock (Toxic Shock Syndrome) 04/2010
1	Anthrax 04/2006

Drug/Important Bio-Agent (IBA)

20	Peptides (Polypeptides)IBA 12/2020 - 04/2006
12	Pharmaceutical PreparationsIBA 01/2020 - 09/2007
7	Proteins (Proteins, Gene)FDA Link 07/2021 - 06/2013
5	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2020 - 01/2016
5	GlycosaminoglycansIBA 12/2020 - 06/2013
5	Antimicrobial PeptidesIBA 01/2020 - 04/2010
5	NeurotensinIBA 01/2015 - 09/2007
3	Heparin (Liquaemin)FDA LinkGeneric 11/2020 - 06/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 01/2017
2	Monoclonal AntibodiesIBA 01/2021 - 06/2014
2	LigandsIBA 11/2020 - 01/2019
2	LDL Receptors (LDL Receptor)IBA 07/2020 - 06/2013
2	tumor-specific tetrabranched peptide NT4IBA 07/2020 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2020 - 12/2015
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 01/2015
2	CytokinesIBA 12/2016 - 04/2010
2	Biological ProductsIBA 12/2015 - 09/2007
2	Liposomes (Liposome)IBA 04/2013 - 04/2011
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	A73025IBA 12/2020
1	SyndecansIBA 12/2020
1	Sulfates (Sulfates, Inorganic)IBA 07/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	SulfatasesIBA 01/2019
1	ProteomeIBA 01/2018
1	Cystatin BIBA 01/2018
1	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 01/2018
1	AnticoagulantsIBA 01/2018
1	prelamin AIBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	Thrombin FDA Link 01/2018
1	Lamin Type A (Lamin A)IBA 01/2018
1	Colistin (Coly-Mycin)FDA Link 10/2017
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 09/2017
1	Heparitin Sulfate (Heparan Sulfate)IBA 09/2017
1	Proteoglycans (Proteoglycan)IBA 09/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2017
1	Membrane Transport Proteins (Biological Pump)IBA 09/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	EnzymesIBA 12/2016
1	Polysaccharides (Glycans)IBA 01/2016
1	Taxoids (Taxanes)IBA 12/2015
1	Tumor Biomarkers (Tumor Markers)IBA 12/2015
1	Protein Isoforms (Isoforms)IBA 04/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 04/2015
1	Gemcitabine FDA Link 01/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2014
1	peptide AIBA 06/2014
1	Adalimumab (Humira)FDA Link 06/2014
1	Anti-Infective Agents (Microbicides)IBA 07/2012
1	Neurotensin Receptors (Neurotensin Receptor)IBA 04/2011
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 04/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2010
1	Peptide Receptors (Peptide Receptor)IBA 04/2010
1	LipopolysaccharidesIBA 04/2010
1	neurotensin (9-13)IBA 09/2007
1	NeuropeptidesIBA 09/2007
1	AntigensIBA 04/2006

Therapy/Procedure

5	Therapeutics 02/2020 - 09/2007
4	Precision Medicine 02/2020 - 06/2013
2	Quantum Dots (Quantum Dot) 02/2020 - 03/2018
1	Drug Therapy (Chemotherapy) 02/2020
1	Respiratory Therapy (Therapy, Respiratory) 01/2020